Literature DB >> 28822085

Nuclear imaging of cardiac amyloidosis.

Efstathia Andrikopoulou1, Pradeep Bhambhvani2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28822085     DOI： 10.1007/s12350-017-1028-3

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  23 in total

1.  Imaging cardiac amyloidosis: a pilot study using ¹⁸F-florbetapir positron emission tomography.

Authors:  Sharmila Dorbala; Divya Vangala; James Semer; Christopher Strader; John R Bruyere; Marcelo F Di Carli; Stephen C Moore; Rodney H Falk
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-20       Impact factor: 9.236

2.  Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis.

Authors:  Arnault Galat; Jean Rosso; Aziz Guellich; Axel Van Der Gucht; Stephane Rappeneau; Diane Bodez; Soulef Guendouz; Claire-Marie Tissot; Luc Hittinger; Jean-Luc Dubois-Randé; Violaine Plante-Bordeneuve; Emmanuel Itti; Michel Meignan; Thibaud Damy
Journal:  Amyloid       Date:  2015-10-14       Impact factor: 7.141

3.  Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

Authors:  R A Kyle; M A Gertz
Journal:  Semin Hematol       Date:  1995-01       Impact factor: 3.851

4.  Cardiac Amyloid Imaging with 18F-Florbetaben PET: A Pilot Study.

Authors:  W Phillip Law; William Y S Wang; Peter T Moore; Peter N Mollee; Arnold C T Ng
Journal:  J Nucl Med       Date:  2016-06-15       Impact factor: 10.057

5.  Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.

Authors:  Adam Castano; Muhammad Haq; David L Narotsky; Jeff Goldsmith; Richard L Weinberg; Rachelle Morgenstern; Ted Pozniakoff; Frederick L Ruberg; Edward J Miller; John L Berk; Angela Dispenzieri; Martha Grogan; Geoffrey Johnson; Sabahat Bokhari; Mathew S Maurer
Journal:  JAMA Cardiol       Date:  2016-11-01       Impact factor: 14.676

6.  Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis.

Authors:  Belinda Ng; Lawreen H Connors; Ravin Davidoff; Martha Skinner; Rodney H Falk
Journal:  Arch Intern Med       Date:  2005-06-27

7.  Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis.

Authors:  Miriam A Stats; James R Stone
Journal:  Cardiovasc Pathol       Date:  2016-07-09       Impact factor: 2.185

8.  (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.

Authors:  Sabahat Bokhari; Adam Castaño; Ted Pozniakoff; Susan Deslisle; Farhana Latif; Mathew S Maurer
Journal:  Circ Cardiovasc Imaging       Date:  2013-02-11       Impact factor: 7.792

Review 9.  Transthyretin (TTR) cardiac amyloidosis.

Authors:  Frederick L Ruberg; John L Berk
Journal:  Circulation       Date:  2012-09-04       Impact factor: 29.690

10.  Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

Authors:  Julian D Gillmore; Mathew S Maurer; Rodney H Falk; Giampaolo Merlini; Thibaud Damy; Angela Dispenzieri; Ashutosh D Wechalekar; John L Berk; Candida C Quarta; Martha Grogan; Helen J Lachmann; Sabahat Bokhari; Adam Castano; Sharmila Dorbala; Geoff B Johnson; Andor W J M Glaudemans; Tamer Rezk; Marianna Fontana; Giovanni Palladini; Paolo Milani; Pierluigi L Guidalotti; Katarina Flatman; Thirusha Lane; Frederick W Vonberg; Carol J Whelan; James C Moon; Frederick L Ruberg; Edward J Miller; David F Hutt; Bouke P Hazenberg; Claudio Rapezzi; Philip N Hawkins
Journal:  Circulation       Date:  2016-04-22       Impact factor: 29.690
View more
  5 in total

Review 1.  Novel Approaches for the Management of AL Amyloidosis.

Authors:  Nisha S Joseph; Jonathan L Kaufman
Journal:  Curr Hematol Malig Rep       Date:  2018-06       Impact factor: 3.952

2.  The evolving landscape of nuclear imaging in cardiac amyloidosis.

Authors:  Steven J Promislow; Terrence D Ruddy
Journal:  J Nucl Cardiol       Date:  2018-05-18       Impact factor: 5.952

3.  Tc-HDP quantitative SPECT/CT in transthyretin cardiac amyloid and the development of a reference interval for myocardial uptake in the non-affected population.

Authors:  Stuart C Ramsay; Karen Lindsay; William Fong; Shaun Patford; John Younger; John Atherton
Journal:  Eur J Hybrid Imaging       Date:  2018-08-22

4.  Technetium-99m pyrophosphate cardiac SPECT in endomyocardial biopsy negative cardiac amyloidosis.

Authors:  Martin Krupa; Rina Nguyen; Jonathan Revels; Lester S Johnson
Journal:  Radiol Case Rep       Date:  2018-07-19

Review 5.  Transthyretin cardiac amyloidosis: a review of the nuclear imaging findings with emphasis on the radiotracers mechanisms.

Authors:  Teodor M Ionescu; Wael Jalloul; Cati R Stolniceanu; Roxana Iacob; Laura P Grecu; Ana-Maria Stătescu; Irena Grierosu; Mihai Guțu; Adrian Gavrilescu; Crișu Daniela; Antoniu Petriș; Manuela Ciocoiu; Cristina Ungureanu; Cipriana Ștefănescu
Journal:  Ann Nucl Med       Date:  2021-07-17       Impact factor: 2.668
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.